Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Casual or Causal? Two Unique Cases of Hodgkin's Lymphoma: A Case Report and Literature Review.

Malik F, Ali N, Jafri SIM, Fidler C.

Am J Case Rep. 2017 May 19;18:553-557.

2.

Immunoglobulin A Lambda Multiple Myeloma in a Patient with HIV: An Unusual Cause of Massive Ascites.

Abdulsamad M, Abbas N, Patel H, Balar B, Khaja M.

Case Rep Gastroenterol. 2017 Apr 10;11(1):201-206. doi: 10.1159/000468516. eCollection 2017 Jan-Apr.

3.

Role of Natural Killer Cells in HIV-Associated Malignancies.

Leal FE, Premeaux TA, Abdel-Mohsen M, Ndhlovu LC.

Front Immunol. 2017 Mar 21;8:315. doi: 10.3389/fimmu.2017.00315. eCollection 2017. Review.

4.

Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.

Riedel DJ, Stafford KA, Vadlamani A, Redfield RR.

AIDS Res Hum Retroviruses. 2017 May;33(5):482-489. doi: 10.1089/AID.2016.0181. Epub 2016 Dec 13.

PMID:
27824263
5.

HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India.

Godbole SV, Nandy K, Gauniyal M, Nalawade P, Sane S, Koyande S, Toyama J, Hegde A, Virgo P, Bhatia K, Paranjape RS, Risbud AR, Mbulaiteye SM, Mitsuyasu RT.

Medicine (Baltimore). 2016 Sep;95(37):e4850. doi: 10.1097/MD.0000000000004850.

6.

A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.

Cornelissen LA, Van Vliet SJ.

Biomolecules. 2016 May 3;6(2). pii: E26. doi: 10.3390/biom6020026. Review.

7.

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma.

Apice G, Pizzolorusso A, Di Maio M, Grignani G, Gebbia V, Buonadonna A, De Chiara A, Fazioli F, De Palma G, Galizia D, Arcara C, Mozzillo N, Perrone F.

Sarcoma. 2016;2016:6862090. doi: 10.1155/2016/6862090. Epub 2016 Feb 25.

8.

Association between Testicular Cancer and Epididymoorchitis: A Population-Based Case-Control Study.

Kao LT, Lin HC, Chung SD, Huang CY.

Sci Rep. 2016 Mar 15;6:23079. doi: 10.1038/srep23079.

9.

Multiple myeloma developing during long-term clinical course of refractory immune thrombocytopenic purpura: a case report and review of literature.

Yao H, Zhang X, Liu J, Zhu L, Chen G, Wu S, Gao L.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):15429-32. eCollection 2015. Review.

10.

Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era.

Sharma SK, Soneja M, Ranjan S.

Indian J Med Res. 2015 Nov;142(5):563-7. doi: 10.4103/0971-5916.171283.

11.

Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.

Lam GY, Halloran BP, Peters AC, Fedorak RN.

World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):181-92. doi: 10.4291/wjgp.v6.i4.181. Review.

12.

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).

Epeldegui M, Lee JY, Martínez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martínez-Maza O.

Clin Cancer Res. 2016 Jan 15;22(2):328-36. doi: 10.1158/1078-0432.CCR-14-0466. Epub 2015 Sep 17.

13.

Immune Protection against Virus Challenge in Aging Mice Is Not Affected by Latent Herpesviral Infections.

Marandu TF, Oduro JD, Borkner L, Dekhtiarenko I, Uhrlaub JL, Drabig A, Kröger A, Nikolich-Zugich J, Cicin-Sain L.

J Virol. 2015 Nov;89(22):11715-7. doi: 10.1128/JVI.01989-15. Epub 2015 Sep 2.

14.

Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era.

Brugnaro P, Morelli E, Cattelan F, Petrucci A, Panese S, Eseme F, Cavinato F, Barelli A, Raise E.

World J Virol. 2015 Aug 12;4(3):209-18. doi: 10.5501/wjv.v4.i3.209. Review.

15.

HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Carroll V, Garzino-Demo A.

Pathog Dis. 2015 Oct;73(7). pii: ftv044. doi: 10.1093/femspd/ftv044. Epub 2015 Jun 29. Review.

16.

Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?

Nassef Kadry Naguib Roufaiel M, Wells JW, Steptoe RJ.

Front Immunol. 2015 Jun 2;6:258. doi: 10.3389/fimmu.2015.00258. eCollection 2015. Review.

17.

A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient.

Choi H, Lee HW, Ann HW, Kim JK, Kang HP, Kim SW, Ku NS, Han SH, Kim JM, Choi JY.

Infect Chemother. 2014 Dec;46(4):257-60. doi: 10.3947/ic.2014.46.4.257. Epub 2014 Dec 29.

18.

Cancer treatment disparities in HIV-infected individuals in the United States.

Suneja G, Shiels MS, Angulo R, Copeland GE, Gonsalves L, Hakenewerth AM, Macomber KE, Melville SK, Engels EA.

J Clin Oncol. 2014 Aug 1;32(22):2344-50. doi: 10.1200/JCO.2013.54.8644. Epub 2014 Jun 30.

19.

Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study.

Akarolo-Anthony SN, Maso LD, Igbinoba F, Mbulaiteye SM, Adebamowo CA.

Infect Agent Cancer. 2014 Mar 5;9(1):1. doi: 10.1186/1750-9378-9-1.

20.

Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.

Chen M, Jen I, Chen YH, Lin MW, Bhatia K, Sharp GB, Law MG, Arthur Chen YM.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):463-72. doi: 10.1097/QAI.0000000000000065.

Supplemental Content

Support Center